Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data (Q28211057)

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Maternal mortality--a neglected tragedy. Where is the M in MCH?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

The safe motherhood initiative: a call to action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Latest advances in understanding preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Early platelet consumption in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

MATERNAL VASCULAR PROSTACYCLIN ACTIVITY IN PRE-ECLAMPSIA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Differential inhibition of prostacyclin production and platelet aggregation by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

A randomised trial of low dose aspirin for primiparae in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Antiplatelet agents for preventing pre-eclampsia and its complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Unraveling the mysteries of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Antioxidants and the Prevention of Preeclampsia — Unresolved Issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Antioxidant supplementation in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Antiplatelet agents for prevention of pre-eclampsia and its consequences: a systematic review and individual patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

The detection, investigation and management of hypertension in pregnancy: full consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Blood-pressure measurement and classification in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Idiopathic recurrent fetal growth retardation and aspirin-dipyridamole therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Administration time-dependent influence of aspirin on blood pressure in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Low-dose aspirin therapy to prevent preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

The classification and definition of the hypertensive disorders of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

The existence of publication bias and risk factors for its occurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960712-0

7 January 2021

10.1016/S0140-6736(07)60712-0

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17512048

1 reference

Consolidated OpenCitations Corpus – April 2017